FDA Asks Manufacturers to Remove Zantac From the Market

The U.S. Food and Drug Administration (FDA) is requesting that all manufacturers immediately withdraw prescription and over-the-counter forms of Zantac from the market after new evidence reportedly shows how certain conditions may raise the level of N-Nitrosodimethylamine (NDMA) in medications containing ranitidine (Zantac).

The request is the latest in an ongoing investigation that started in the summer of 2019, prompting the agency to issue a statement alerting patients and health care professionals of the possible risks associated with the heartburn medication.

If you or your loved one has been injured after using Zantac, or a similar drug containing ranitidine, contact Attorney Group today. Affected patients and their families may be able to pursue a claim and recover compensation with the help of a dangerous drug attorney.

For more information, contact Attorney Group. We offer free, confidential, no obligation consultations. We can help answer your questions, and if you choose to pursue a claim, we can connect you with an affiliated attorney who can assist you throughout the legal process.

The time you have to pursue a claim is limited. Contact us for more information.Get Help Now.

New Evidence Links Certain Conditions to Increased Levels of NDMA

On April 1, 2020, the FDA announced that new studies and information from third-party laboratories confirmed the increase in the level of NDMA in ranitidine when the product is stored at higher temperatures. Testing also reportedly indicated that the longer a ranitidine product sits on a store’s shelf or in the home of a consumer, the greater the level of NDMA.

In the summer of 2019, the FDA was notified that independent testing had discovered NDMA, a probable human carcinogen, in products containing ranitidine. While low levels of NDMA are commonly present in foods and water, exposure to higher levels of the substance could potentially lead to an increased risk of cancer.

Along with its announcement to remove all Zantac products from the market, the FDA is advising consumers to stop taking over-the-counter versions of the product and to get rid of any products they currently possess. Consumers who want to continue to use the medication are being asked to consider using a similar product, and those who are prescribed the medication are encouraged to speak with their health care provider or doctor about other options for treatment.

How Can an Attorney Help?

Drug makers have a duty to provide safe products. If there are risks of harm associated with their products, they also must provide adequate warnings. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

People injured by Zantac and other similar heartburn medications containing ranitidine may be able to recover money for:

  • Medical expenses
  • Lost wages
  • Pain and suffering

The families of those who have died may be eligible to recover money for funeral expenses and the pain that comes with losing a loved one.

The Time You Have to Pursue a Claim is Limited. Contact Us Today.

For more information, contact Attorney Group. After you contact us, an attorney will follow up to answer questions that you might have.

There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim or file a lawsuit for an injury. If you think you have a case, you should not delay taking action.